Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4743 stock hub

TPEX/4743 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/4743is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
24.7B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/4743
In the news

Latest news · TPEX/4743

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-9.1
P25 -16.2P50 0.3P75 9.8
ROIC-15.3
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/4743 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
195
Groups with data
11
Currency
TWD
Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Taiwan
Country code
TW
Employees
43
Employees Change
6%
Employees Change Percent
16.22
Enterprise value
TWD 19.4B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0004743000
Last refreshed
2026-05-10
Market cap
TWD 24.7B
Price
TWD 51.6
Price currency
TWD
Rev Per Employee
3,002,860.47x
Sector
Healthcare
Sic
2836
Symbol
tpex/4743
Website
https://www.onenessbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-4.23%
EV Earnings
-18.59x
EV/FCF
-40.27x
EV/Sales
150.4x
FCF yield
-1.95%
P/B ratio
2.36x
P/S ratio
191.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
Gross margin
30.88%
Gross Profit
TWD 39.9M
Gross Profit Growth
-36.74%
Gross Profit Growth Q
103.19%
Gross Profit Growth3 Y
-63.85%
Gross Profit Growth5 Y
5.36%
Net Income
TWD -1B
Net Income Growth Quarters
2%
Net Income Growth Years
2%
Pretax Margin
-817.87%
Profit Per Employee
TWD -24.3M
ROA
-3.95
Roa5y
-3.51
ROCE
-7.16
ROE
-9.1
Roe5y
-5.42
ROIC
-15.31
Roic5y
-12.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
8.14%
Cagr15y
11.49%
Cagr1y
-10.11%
Cagr3y
-36.85%
Cagr5y
-23.48%
Div CAGR10
0%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth Quarters
2
EPS Growth Years
2
Revenue Growth
9.5x
Revenue Growth Q
37.56x
Revenue Growth Quarters
2x
Revenue Growth Years
2x
Revenue Growth3 Y
-50.51x
Revenue Growth5 Y
25.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
TWD 0.01
Assets
TWD 11.7B
Cash
TWD 5.8B
Current Assets
TWD 6.2B
Current Liabilities
TWD 521.4M
Debt
TWD 370.7M
Debt Equity
TWD 0.04
Debt FCF
TWD -0.77
Equity
TWD 10.5B
Interest Coverage
-90.22
Liabilities
TWD 1.3B
Long Term Assets
TWD 5.6B
Long Term Liabilities
TWD 735M
Net Cash
TWD 5.5B
Net Cash By Market Cap
TWD 22.05
Net Cash Growth
-17.54%
Net Debt Equity
TWD -0.52
Tangible Book Value
TWD 9.3B
Tangible Book Value Per Share
TWD 19.49
WACC
8.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
11.81
Inventory Turnover
0.8
Net Working Capital
TWD -143.8M
Quick ratio
11.44
Working Capital
TWD 5.6B
Working Capital Turnover
TWD 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.25%
Dividend per share
TWD 0
Last Dividend
TWD 0.09

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
118.68%
1Y total return
-10.1%
200-day SMA
62.4
3Y total return
-74.83%
50-day SMA
53.78
50-day SMA vs 200-day SMA
50under200
5Y total return
-73.76%
All Time High
398.9
All Time High Change
-87.06%
All Time High Date
2020-07-09
All Time Low
8.17
All Time Low Change
531.5%
All Time Low Date
2010-05-13
ATR
2.29
Beta
0.79
Beta1y
0.63
Beta2y
0.7
Ch YTD
-7.19
High
53.7
High52
82.7
High52 Date
2025-09-08
High52ch
-37.61%
Low
51.5
Low52
49.7
Low52 Date
2026-03-23
Low52ch
3.82%
Ma50ch
-4.06%
Price vs 200-day SMA
-17.31%
RSI
44.23
RSI Monthly
31.94
RSI Weekly
39.93
Sharpe ratio
-0.17x
Sortino ratio
-0.13
Total Return
-0.25%
Tr YTD
-7.19
Tr15y
411.11%
Tr1m
-5.32%
Tr1w
-4.8%
Tr3m
-12.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -803M
Operating margin
-621.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
300,050,136%
Net Borrowing
-43,015,000
Shares Insiders
9.33%
Shares Institutions
4.37%
Shares Out
479,214,000
Shares Qo Q
0.03%
Shares Yo Y
0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
TWD -510.1M
Average Volume
2,234,175.5x
Bv Per Share
21.56
CAPEX
TWD -22M
Ch10y
118.6
Ch15y
389.7
Ch1m
-5.32
Ch1w
-4.8
Ch1y
-10.1
Ch3m
-12.1
Ch3y
-74.84
Ch5y
-73.77
Ch6m
-15.41
Change
-2.46%
Change From Open
-3.19
Close
52.9
Days Gap
0.76
Depreciation Amortization
286,502,000
Dollar Volume
108,855,205.2
Earnings Date
2026-05-13
EBIT
TWD -803M
EBITDA
TWD -516.5M
EPS
TWD -2.18
F Score
2
FCF
TWD -482.2M
FCF EV Yield
-2.48x
FCF Per Share
TWD -1.01
Financing CF
-12,493,000
Fiscal Year End
December
Founded
2,008
Goodwill
57,441,000
Income Tax
TWD 3.5M
Investing CF
1,076,808,000
Is Primary Listing
1
Last Earnings Date
2025-11-11
Last Report Date
2025-12-31
Last Split Date
2024-07-26
Last Split Type
Forward
Ma150
60.38
Ma150ch
-14.54%
Ma20
53.1
Ma20ch
-2.82%
Net CF
610,971,000
Next Earnings Date
2026-05-13
Open
53.3
Position In Range
4.55
Ppne
994,894,000
Price Date
2026-05-08
Ptbv Ratio
2.65
Relative Volume
0.96x
Revenue
129,123,000x
SBC By Revenue
21.58x
Share Based Comp
27,865,000
Tax By Revenue
2.68x
Tr6m
-15.41%
Volume
2,109,597
Z Score
15.59
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/4743 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4743 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-10.1%
S&P 500 1Y: n/a
3Y total return
-74.8%
S&P 500 3Y: n/a
5Y total return
-73.8%
S&P 500 5Y: n/a
10Y total return
+118.7%
S&P 500 10Y: n/a
Ownership

Who owns TPEX/4743?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.4%
Share of float held by funds and institutions
Insider ownership
+9.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

TPEX/4743 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.2
Neutral momentum band
Price vs 200-day MA
-17.3%
50/200-day relationship not available
Beta (5Y)
0.79
Less volatile than the market
Sharpe ratio
-0.17
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/4743

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4743 stock rating?

tpex/4743 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4743 analysis?

The full report lives at /stocks/tpex/4743/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4743?

The latest report frames tpex/4743 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4743 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tpex/4743 stock profile: metrics, valuation and analysis | StockMarketAgent.AI